Cargando…

Targeted agents in epithelial ovarian cancer: review on emerging therapies and future developments

Epithelial ovarian cancer (EOC) remains a clinical challenge and there is a need to optimise the currently available treatment and to urgently develop new therapeutic strategies. Recently, there has been improved understanding of the molecular characteristics and tumour microenvironment of ovarian c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lokadasan, Rajitha, James, Francis V, Narayanan, Geetha, Prabhakaran, Pranab K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cancer Intelligence 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4817523/ https://www.ncbi.nlm.nih.gov/pubmed/27110282 http://dx.doi.org/10.3332/ecancer.2016.626

Ejemplares similares

Rhabdomyosarcoma of prostate presenting as bladder outlet obstruction in a young adult
por: Prabhakaran, Pranab, et al.
Publicado: (2013)

Hypercalcaemia with disseminated osteolytic lesions: a rare presentation of childhood acute lymphoblastic leukaemia
por: Lokadasan, Rajitha, et al.
Publicado: (2015)

Metastatic lobular carcinoma of breast mimics primary cervix carcinoma: two case reports and a review of the literature
por: Lokadasan, Rajitha, et al.
Publicado: (2015)

Targeted Therapies in Epithelial Ovarian Cancer
por: Barrena Medel, Nicanor I., et al.
Publicado: (2010)

Targeted Therapies in Epithelial Ovarian Cancer
por: Dean, Emma, et al.
Publicado: (2010)

Epithelial Ovarian Cancer: Focus on Targeted Therapy
por: Markman, M., et al.
Publicado: (2010)

Palliative Radiation Therapy for Metastatic, Persistent, or Recurrent Epithelial Ovarian Cancer: Efficacy in the Era of Modern Technology and Targeted Agents
por: Butala, Anish A., et al.
Publicado: (2020)

Ovarian cancer: emerging molecular-targeted therapies
por: Sourbier, Carole
Publicado: (2012)

Autophagy as an emerging therapy target for ovarian carcinoma
por: Zhan, Lei, et al.
Publicado: (2016)

Emerging Metabolic Targets in the Therapy of Hematological Malignancies
por: Leni, Zaira, et al.
Publicado: (2013)

Emerging antiplatelet agents, differential pharmacology, and clinical utility
por: Das, Pranab, et al.
Publicado: (2010)

Maintenance therapy for recurrent epithelial ovarian cancer: current therapies and future perspectives – a review
por: Gupta, Sudeep, et al.
Publicado: (2019)

PARP inhibitors and epithelial ovarian cancer: Molecular mechanisms, clinical development and future prospective
por: Loizzi, Vera, et al.
Publicado: (2020)

Targeting the Epidermal Growth Factor Receptor in Epithelial Ovarian Cancer: Current Knowledge and Future Challenges
por: Siwak, Doris R., et al.
Publicado: (2010)

Harnessing Wnt signaling as a targetable therapy in epithelial ovarian cancer
por: Wall, Jaclyn A., et al.
Publicado: (2020)

Targeted therapy and immunotherapy: Diamonds in the rough in the treatment of epithelial ovarian cancer
por: Huang, Xu, et al.
Publicado: (2023)

Antibody-Drug Conjugates for Breast Cancer Treatment: Emerging Agents, Targets and Future Directions
por: Yang, Tinglin, et al.
Publicado: (2023)

Antivascular Therapy for Epithelial Ovarian Cancer
por: Duhoux, Francois P., et al.
Publicado: (2010)

Local estrogen metabolism in epithelial ovarian cancer suggests novel targets for therapy
por: Ren, Xia, et al.
Publicado: (2015)

Histone deacetylases as new therapy targets for platinum-resistant epithelial ovarian cancer
por: Pchejetski, Dmitri, et al.
Publicado: (2015)

Folate Transport and One-Carbon Metabolism in Targeted Therapies of Epithelial Ovarian Cancer
por: Wallace-Povirk, Adrianne, et al.
Publicado: (2021)

“Pool sign” in Cerebral Metastatic Adenocarcinoma
por: Cherian, Ajith, et al.
Publicado: (2020)

Response to microtubule-interacting agents in primary epithelial ovarian cancer cells
por: Pellicciotta, Ilenia, et al.
Publicado: (2013)

Novel Ex Vivo Models of Epithelial Ovarian Cancer: The Future of Biomarker and Therapeutic Research
por: Clark, James, et al.
Publicado: (2022)

HIF-1α Is a Rational Target for Future Ovarian Cancer Therapies
por: Wang, Xin, et al.
Publicado: (2021)

Highly Charged Ru(II) Polypyridyl Complexes as Photosensitizer Agents in Photodynamic Therapy of Epithelial Ovarian Cancer Cells
por: Conti, Luca, et al.
Publicado: (2022)

Targeting Signaling Pathways in Epithelial Ovarian Cancer
por: Smolle, Elisabeth, et al.
Publicado: (2013)

Recent Developments in Glioblastoma Therapy: Oncolytic Viruses and Emerging Future Strategies
por: Hamad, Azzam, et al.
Publicado: (2023)

Mitochondria-targeted organic sonodynamic therapy agents: concept, benefits, and future directions
por: Hwang, Eunbin, et al.
Publicado: (2023)

Repurposing Itraconazole and Hydroxychloroquine to Target Lysosomal Homeostasis in Epithelial Ovarian Cancer
por: Marastoni, Stefano, et al.
Publicado: (2022)

Hormone replacement therapy and risk of epithelial ovarian cancer
por: Purdie, D M, et al.
Publicado: (1999)

Patient-Derived Xenograft Models to Improve Targeted Therapy in Epithelial Ovarian Cancer Treatment
por: Scott, Clare L., et al.
Publicado: (2013)

Genetic and epigenetic heterogeneity of epithelial ovarian cancer and the clinical implications for molecular targeted therapy
por: Bai, Huimin, et al.
Publicado: (2016)

Target Selection for T-Cell Therapy in Epithelial Ovarian Cancer: Systematic Prioritization of Self-Antigens
por: Schossig, Paul, et al.
Publicado: (2023)

Past, Present, and Future: Development of Theranostic Agents Targeting Carbonic Anhydrase IX
por: Lau, Joseph, et al.
Publicado: (2017)

The Emerging Role of PARP Inhibitors in the Treatment of Epithelial Ovarian Cancer
por: Gien, Lilian T., et al.
Publicado: (2010)

The emerging roles and therapeutic potential of exosomes in epithelial ovarian cancer
por: Li, Xiaoduan, et al.
Publicado: (2017)

Modelling Epithelial Ovarian Cancer in Mice: Classical and Emerging Approaches
por: Zakarya, Razia, et al.
Publicado: (2020)

Impact of the COVID-19 Pandemic on Indian Cancer Patients
por: Anoop, T. M., et al.
Publicado: (2021)

Predictive and Prognostic Protein Biomarkers in Epithelial Ovarian Cancer: Recommendation for Future Studies
por: Le Page, Cécile, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_s90depskueekn78ohrgidgap5c